» Articles » PMID: 36605300

Methods of Low-Density Lipoprotein-Cholesterol Measurement: Analytical and Clinical Applications

Overview
Journal EJIFCC
Specialty Biochemistry
Date 2023 Jan 6
PMID 36605300
Authors
Affiliations
Soon will be listed here.
Abstract

Among the five major classes of lipoprotein particles, low-density lipoprotein-cholesterol (LDL-C) is the primary lipoprotein risk factor for the development of cardiovascular diseases (CVD) through the promotion of atherosclerotic pathogenesis. Therefore, it is of paramount importance to accurately measure the plasma concentration of LDL-C using an appropriate method to examine the risk of CVD and determine the efficacy of therapeutic interventions to reduce the cholesterol level and examine the risk assessment strategy. At present, there is a wide variety of methods available for LDL-C measurement. In this review, we have outlined the commonly used methods of LDL-C measurement. These methods have been classified into non-automated analytical methods, calculation methods, and automated direct measurement of LDL-C. We have also described some recently proposed promising calculation methods which are being considered for clinical adoption. This current review could assist the clinicians to have a better understanding regarding the measurement techniques and comparative utilities of different methods of LDL-C measurement and guide them to select an appropriate method based on accuracy, turnaround time, and cost of test.

Citing Articles

Reducing LDL-Cholesterol to Very Low Levels: Sailing Between Established Benefits and Potential Risks.

Di Fusco S, Volpe M, Nardi F, Matteucci A, Aquilani S, Marino G High Blood Press Cardiovasc Prev. 2025; 32(2):139-149.

PMID: 39998740 DOI: 10.1007/s40292-025-00708-x.


The triglyceride-glucose index and acute kidney injury risk in critically ill patients with coronary artery disease.

Zhang Y, Li G, Li J, Jian B, Wang K, Chen J Ren Fail. 2025; 47(1):2466818.

PMID: 39972619 PMC: 11843639. DOI: 10.1080/0886022X.2025.2466818.


A new prognostic model based on serum apolipoprotein AI in patients with HBV-ACLF and acutely decompensated liver cirrhosis.

Mo R, Zhang Z, Zhou Y, Wang Y, Yin P, Zhang C Lipids Health Dis. 2025; 24(1):35.

PMID: 39901194 PMC: 11789380. DOI: 10.1186/s12944-025-02434-8.


Challenges and Future Directions in Lipoprotein Measurement for Atherosclerosis Prevention and Treatment.

Konishi T Int J Mol Sci. 2025; 25(24.

PMID: 39769011 PMC: 11676963. DOI: 10.3390/ijms252413247.


L-carnitine attenuates autophagic flux, apoptosis, and necroptosis in rats with dexamethasone-induced non-alcoholic steatohepatitis.

Amer A, Ghoneim H, Abdelaziz R, Shehatou G, Suddek G BMC Pharmacol Toxicol. 2024; 25(1):102.

PMID: 39736705 PMC: 11684100. DOI: 10.1186/s40360-024-00820-z.


References
1.
Nauck M, Warnick G, Rifai N . Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem. 2002; 48(2):236-54. View

2.
Mulder K, van Leeuwen C, Schouten J, van Gent C, Snel M, Lahey J . An evaluation of three commercial methods for the determination of LDL-cholesterol. Clin Chim Acta. 1984; 143(1):29-35. DOI: 10.1016/0009-8981(84)90034-2. View

3.
Kanonidou C . Small dense low-density lipoprotein: Analytical review. Clin Chim Acta. 2021; 520:172-178. DOI: 10.1016/j.cca.2021.06.012. View

4.
Esteban-Salan M . Analytical and clinical evaluation of two homogeneous assays for LDL-cholesterol in hyperlipidemic patients. Clin Chem. 2000; 46(8 Pt 1):1121-31. View

5.
Mizutani H, Sako T, Arai N, Kuriyama K, Yoshimura I, Mori A . Application of gel permeation HPLC for lipoprotein profiling in dogs. J Vet Med Sci. 2010; 72(6):813-7. DOI: 10.1292/jvms.09-0500. View